GAITHERSBURG, Md., Nov. 5, 2019 /PRNewswire/ -- Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer and autoimmune diseases, today announced that it has initiated a Phase 1/2 clinical trial (

BRIDGEWATER, N.J., Nov. 5, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:The Credit Suisse 28th Annual Healthcare Confer

NEW YORK, Nov. 5, 2019 /PRNewswire/ -- Royalty Pharma announced today that it has agreed to pay $330 million to purchase Eisai Co., Ltd.'s royalties on future worldwide sales of tazemetostat, Epizyme Inc.'s (Nasdaq: EPZM) lead investigational agent, outside of Japan, and made an equity investment in Epizyme o

INCHINNAN, Scotland, Nov. 5, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced that it is investing nearly $24 million in its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity

SAN JOSE, California, Nov. 5, 2019 /PRNewswire/ -- Verix (www.verix.com), a global leader in advanced data & analytic solutions for Commercial Operations in the Life Sciences industry, announces that Ironshore Pharmaceuticals Inc. has selected its analytic platform to support the commercializatio

LOVELAND, Colo., Nov. 5, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty healthcare products, today reported financial results for its third quarter ended September 30, 2019. The Company reports results in two segments: Core Companion Animal ("

SAN DIEGO, Nov. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has awarded AnaBios an exclusive Indefinite Delivery Indefinite Quantity (IDIQ) contract to employ adult human primary tissues and cardiomyocytes from organ donors to assess drug safety related to cardiac function.

SAN DIEGO, Nov. 5, 2019 /PRNewswire/ -- IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services today announced that it has been awarded a new "Drug Formulation and Manufacturing" contract by the Office of Logistics and Office of Administration at the National Institutes of Health

CARLSBAD, Calif., Nov. 5, 2019 /PRNewswire/ -- ChromaCode, Inc., a next-generation molecular diagnostics company using data science to significantly enhance multiplexing capabilities of life science instrumentation, today announced the Company will launch its second highly-multiplexed real-time PCR assay, the HDPCR™ Multi-Drug Resistance (MDR) Panel, and prese

YOKNEAM, Israel, Nov. 5, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the third quarter ended September 30, 2019.